S100A9 and Alzheimer disease: This finding suggests that the expression of these four RBP genes (IFI16, S100A9, PKM, and ENO1) may affect the occurrence and development of AD by regulating AS in biological pathways related to cytoskeleton organization, inflammatory response, and immune response.